Research indicates that certain statins, particularly atorvastatin and simvastatin, may elevate the risk of erectile ...
Morning Overview on MSN
A VA study of 588,000 patients ties GLP-1 drugs to a 35% higher risk of vision loss
Millions of Americans taking GLP-1 receptor agonists for type 2 diabetes or weight loss now face a new safety question. A ...
Morning Overview on MSN
A huge Lancet study says statins don’t cause most of the side effects on their labels
Millions of people who take statins for heart disease prevention have been warned about dozens of possible side effects on ...
Amazon's new cloud infrastructure, known as resilient network graph (RNG), claims to be faster, cheaper, and less ...
Most people can feel the gap without thinking about it. One hand writes neatly, throws cleanly, and handles tools with ease.
CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.
The transmission of optical information through random scattering media is a major challenge in optics, biomedical imaging, ...
Scientists are using AI and physics-based simulations together to design new peptides that will kill previously ...
In patients with septic shock, early vasopressor therapy plus restricted fluid administration does not improve 90-day outcomes compared with greater fluid administration with later vasopressor use.
FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States.FDA agrees with the clinical protocol ...
The trial is real, and it is a meaningful step. It is also, by design, small, tightly controlled, and years away from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results